Back to search

Switzerland· 36290013

Spersapolymyxin, Augentropfen

A kombinationen von antibiotika product containing polymyxini b sulfas, neomycinum, registered in Switzerland by OmniVision AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC S01AA30

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSpersapolymyxin, AugentropfenATCS01AA30REGISTER NO.36290013PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Kombinationen von antibiotika is registered in 7 of 19 countries.

Countries holding a registration under ATC S01AA30 (kombinationen von antibiotika), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose

Kombinationen von antibiotika · ATC S01AA30

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
polymyxini B sulfas, neomycinum
Manufacturer
OmniVision AG
Country
Switzerland (CH)
ATC code
S01AA30
ATC class
Kombinationen von Antibiotika
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680362900137
    5 ml
    CHF 14.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Kombinationen von antibiotika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All kombinationen von antibiotika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0e3b53d-c996-4357-8d0b-23fae988cfec
GET /v1/drugs/c0e3b53d-c996-4357-8d0b-23fae988cfec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "polymyxini b sulfas 1.5 mg + neomycinum 3.5 mg",
  "valid_from": "1972-03-15",
  "limitations": null,
  "galenic_form": "Gtt Opht",
  "therapeutic_area": null,
  "sl_inclusion_date": "1972-03-15",
  "self_retention_pct": 10
}

See everything about kombinationen von antibiotika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.